10-60196628-GAAA-GAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_020987.5(ANK3):c.1690-4delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0189 in 1,225,208 control chromosomes in the GnomAD database, including 37 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.010 ( 11 hom., cov: 28)
Exomes 𝑓: 0.020 ( 26 hom. )
Consequence
ANK3
NM_020987.5 splice_region, intron
NM_020987.5 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.469
Publications
5 publications found
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 10-60196628-GA-G is Benign according to our data. Variant chr10-60196628-GA-G is described in ClinVar as Benign. ClinVar VariationId is 1174830.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0103 (1370/133074) while in subpopulation SAS AF = 0.0166 (70/4206). AF 95% confidence interval is 0.0135. There are 11 homozygotes in GnomAd4. There are 740 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR,Unknown,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ANK3 | NM_020987.5 | c.1690-4delT | splice_region_variant, intron_variant | Intron 14 of 43 | ENST00000280772.7 | NP_066267.2 | ||
| ANK3 | NM_001204404.2 | c.1639-4delT | splice_region_variant, intron_variant | Intron 14 of 43 | NP_001191333.1 | |||
| ANK3 | NM_001320874.2 | c.1690-4delT | splice_region_variant, intron_variant | Intron 14 of 42 | NP_001307803.1 | |||
| ANK3 | NM_001204403.2 | c.1672-4delT | splice_region_variant, intron_variant | Intron 15 of 43 | NP_001191332.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0103 AC: 1368AN: 133040Hom.: 11 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
1368
AN:
133040
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0552 AC: 6239AN: 113098 AF XY: 0.0551 show subpopulations
GnomAD2 exomes
AF:
AC:
6239
AN:
113098
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0200 AC: 21819AN: 1092134Hom.: 26 Cov.: 21 AF XY: 0.0204 AC XY: 11153AN XY: 547070 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
21819
AN:
1092134
Hom.:
Cov.:
21
AF XY:
AC XY:
11153
AN XY:
547070
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
533
AN:
25728
American (AMR)
AF:
AC:
704
AN:
31448
Ashkenazi Jewish (ASJ)
AF:
AC:
1286
AN:
20300
East Asian (EAS)
AF:
AC:
413
AN:
32278
South Asian (SAS)
AF:
AC:
2074
AN:
65372
European-Finnish (FIN)
AF:
AC:
1001
AN:
35426
Middle Eastern (MID)
AF:
AC:
150
AN:
4540
European-Non Finnish (NFE)
AF:
AC:
14597
AN:
831336
Other (OTH)
AF:
AC:
1061
AN:
45706
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.333
Heterozygous variant carriers
0
1905
3810
5715
7620
9525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
600
1200
1800
2400
3000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0103 AC: 1370AN: 133074Hom.: 11 Cov.: 28 AF XY: 0.0116 AC XY: 740AN XY: 63838 show subpopulations
GnomAD4 genome
AF:
AC:
1370
AN:
133074
Hom.:
Cov.:
28
AF XY:
AC XY:
740
AN XY:
63838
show subpopulations
African (AFR)
AF:
AC:
493
AN:
37134
American (AMR)
AF:
AC:
91
AN:
13044
Ashkenazi Jewish (ASJ)
AF:
AC:
168
AN:
3192
East Asian (EAS)
AF:
AC:
36
AN:
4680
South Asian (SAS)
AF:
AC:
70
AN:
4206
European-Finnish (FIN)
AF:
AC:
113
AN:
7012
Middle Eastern (MID)
AF:
AC:
5
AN:
268
European-Non Finnish (NFE)
AF:
AC:
373
AN:
60966
Other (OTH)
AF:
AC:
21
AN:
1790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
65
131
196
262
327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.